New York State Common Retirement Fund’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-61,094
| Closed | -$924K | – | 3273 |
|
|
2022
Q3 | $924K | Sell |
61,094
-49,818
| -45% | -$579K | ﹤0.01% | 2019 |
|
|
2022
Q2 | $832K | Buy |
110,912
+10,399
| +10% | +$73.3K | ﹤0.01% | 2119 |
|
|
2022
Q1 | $915K | Sell |
100,513
-12,731
| -11% | -$98.1K | ﹤0.01% | 2154 |
|
|
2021
Q4 | $795K | Sell |
113,244
-1,105
| -1% | -$11.6K | ﹤0.01% | 2197 |
|
|
2021
Q3 | $1.3M | Sell |
114,349
-6,441
| -5% | -$94.2K | ﹤0.01% | 1999 |
|
|
2021
Q2 | $1.93M | Buy |
120,790
+1,340
| +1% | +$23K | ﹤0.01% | 1891 |
|
|
2021
Q1 | $2.13M | Buy |
119,450
+63,717
| +114% | +$1.1M | ﹤0.01% | 1741 |
|
|
2020
Q4 | $753K | Buy |
55,733
+24,733
| +80% | +$299K | ﹤0.01% | 2158 |
|
|
2020
Q3 | $365K | Hold |
31,000
| – | – | ﹤0.01% | 2368 |
|
|
2020
Q2 | $458K | Sell |
31,000
-6,900
| -18% | -$102K | ﹤0.01% | 2269 |
|
|
2020
Q1 | $512K | Hold |
37,900
| – | – | ﹤0.01% | 2021 |
|
|
2019
Q4 | $916K | Sell |
37,900
-5,400
| -12% | -$112K | ﹤0.01% | 1990 |
|
|
2019
Q3 | $832K | Hold |
43,300
| – | – | ﹤0.01% | 2074 |
|
|
2019
Q2 | $1.28M | Sell |
43,300
-17,685
| -29% | -$681K | ﹤0.01% | 1889 |
|
|
2019
Q1 | $2.9M | Buy |
60,985
+26,085
| +75% | +$1.15M | ﹤0.01% | 1451 |
|
|
2018
Q4 | $1.26M | Sell |
34,900
-4,700
| -12% | -$220K | ﹤0.01% | 1781 |
|
|
2018
Q3 | $2.44M | Hold |
39,600
| – | – | ﹤0.01% | 1574 |
|
|
2018
Q2 | $2.67M | Buy |
39,600
+2,600
| +7% | +$145K | ﹤0.01% | 1531 |
|
|
2018
Q1 | $2.01M | Buy |
37,000
+1,800
| +5% | +$101K | ﹤0.01% | 1629 |
|
|
2017
Q4 | $2.1M | Sell |
35,200
-2,451
| -7% | -$149K | ﹤0.01% | 1608 |
|
|
2017
Q3 | $1.83M | Sell |
37,651
-12,573
| -25% | -$686K | ﹤0.01% | 1686 |
|
|
2017
Q2 | $2.64M | Buy |
50,224
+8,838
| +21% | +$412K | ﹤0.01% | 1535 |
|
|
2017
Q1 | $1.88M | Buy |
41,386
+7,826
| +23% | +$349K | ﹤0.01% | 1712 |
|
|
2016
Q4 | $1.27M | Hold |
33,560
| – | – | ﹤0.01% | 1927 |
|
|
2016
Q3 | $1.27M | Buy |
33,560
+1,013
| +3% | +$22.3K | ﹤0.01% | 1892 |
|
|
2016
Q2 | $573K | Buy |
32,547
+3,900
| +14% | +$63.1K | ﹤0.01% | 2225 |
|
|
2016
Q1 | $348K | Hold |
28,647
| – | – | ﹤0.01% | 2415 |
|
|
2015
Q4 | $698K | Buy |
28,647
+1,627
| +6% | +$38K | ﹤0.01% | 2162 |
|
|
2015
Q3 | $479K | Buy |
27,020
+9,372
| +53% | +$170K | ﹤0.01% | 2339 |
|
|
2015
Q2 | $311K | Buy |
+17,648
| New | +$324K | ﹤0.01% | 2740 |
|
New York State Common Retirement Fund's AERI Position: Q4 2022 in Review
New York State Common Retirement Fund sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 61,094 shares — an estimated $924K sold.
New York State Common Retirement Fund first reported a position in AERI in Q2 2015 and held it in 30 quarters. The position peaked at $2.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- New York State Common Retirement Fund reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- New York State Common Retirement Fund sold 61,094 Aerie Pharmaceuticals shares in Q4 2022, an estimated $924K.
- New York State Common Retirement Fund first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 30 quarters.
- New York State Common Retirement Fund's Aerie Pharmaceuticals position peaked at $2.9M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on New York State Common Retirement Fund's 13F filing for Q4 2022, filed 30 Jan 2023.